NCT04144192View on ClinicalTrials.gov

Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 28, 2014

Primary Completion Date

July 24, 2014

Study Completion Date

July 24, 2014

Conditions
Healthy
Interventions
DRUG

Lidocaine patch 1.8%

DRUG

Lidocaine 5% patch

DRUG

Lidocaine 2% Injectable Solution

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT04144192 - Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects | Biotech Hunter | Biotech Hunter